Serial positron emission tomography scans following radiation therapy of patients with head and neck cancer

Head and Neck

Volumn 23, Issue 11, 2001, Pages 942-946

  Greven, Kathryn M ^a   Williams III, Daniel W ^a   Frederick McGuirt Sr , W ^a   Harkness, Beth A ^a   D'Agostino Jr , Ralph B ^a   Keyes Jr , John W ^a   Watson Jr , Nat E ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Cancer; Head and neck cancer; Positron emission tomography; Standard uptake values

Indexed keywords

FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ARTICLE; CALCULATION; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC PROCEDURE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEAD AND NECK CANCER; HUMAN; INTERMETHOD COMPARISON; LEAN BODY WEIGHT; MINIMAL RESIDUAL DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PRIORITY JOURNAL; TREATMENT OUTCOME; TREATMENT PLANNING; TUMOR BIOPSY;

FLUORODEOXYGLUCOSE F18; HEAD AND NECK NEOPLASMS; HUMANS; OROPHARYNGEAL NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS;

EID: 0034767929     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.1136     Document Type: Article

References (13)

1. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation
2. Serum glucose: Effects on tumor and normal tissue accumulation of 2-(F-18)-fluoro-2-desoxy-D-glucose in rodents with mammary carcinoma
3. Standardized uptake values of normal tissues at PET with 2- (fluorine-18)-fluoro-2-deoxy-D-glucose: Variations with body weight and a method for correction
4. Primary and recurrent early stage laryngeal cancer: Preliminary results of 2-[fluorine-18]-fluoro-2-deoxy-D-glucose PET imaging
5. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma
6. 18 FDG-PET for the assessment of primary head and neck tumors: Clinical, computed tomography, and histopathological correlation in 38 patients
7. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas
8. Evaluation of chemotherapy response in patients with advanced had and neck cancer using [F-18]fluorodeoxyglucose positron emission tomography
9. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography
10. Surveillance for recurrent head and neck cancer using positron emission tomography
11. Positron emission tomography: An independent indicator of radiocurability in head and neck carcinomas
12. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer
13. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer